Commission Implementing Regulation (EU) 2019/716 of 30 April 2019 amending Implementing Regulations (EU) No 22/2013 and (EU) No 540/2011 as regards the conditions of approval of the active substance cyflumetofen (Text with EEA relevance.)

• CELEX: Implementing Regulation (EU) 2019/716
• Articles: 7

Article 1 Amendment to Implementing Regulation (EU) No 22/2013

Annex I to Implementing Regulation (EU) No 22/2013 is amended in accordance with Annex I to this Regulation.

Article 2 Amendment to Implementing Regulation (EU) No 540/2011

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex II to this Regulation.

Article 3 Transitional measures

Member States shall, where necessary, withdraw or amend authorisations for plant protection products containing cyflumetofen as active substance by 30 November 2019 at the latest.

Article 4 Grace period

Any grace period granted by Member States in accordance with Article 46 of Regulation (EC) No 1107/2009 shall be as short as possible and shall expire by 30 May 2020 at the latest.

Article 5 Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX I

ANNEX I

In Annex I to Implementing Regulation (EU) No 22/2013, the column ‘Specific provisions’ is replaced by the following:

‘Plant protection products containing cyflumetofen shall only be authorised for uses where the level of metabolite B3 in groundwater is expected to be below 0,1 μg/L.

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on cyflumetofen, and in particular Appendices I and II thereto, as finalised in the Standing Committee on the Food Chain and Animal Health on 20 November 2012 shall be taken into account.

In this overall assessment, Member States shall pay particular attention to:

—

the protection of operators and workers;

—

the protection of groundwater, in particular for metabolite B3, when the substance is applied in regions with vulnerable soils and/or climatic conditions;

—

the protection of drinking water;

—

the risk to aquatic organisms.

Conditions of use shall include risk mitigation measures, where appropriate.’

ANNEX II

ANNEX II

The column ‘Specific provisions’ of row 31, cyflumetofen, in Part B of the Annex to Implementing Regulation (EU) No 540/2011 is replaced by the following:

‘Plant protection products containing cyflumetofen shall only be authorised for uses where the level of metabolite B3 in groundwater is expected to be below 0,1 μg/L.

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on cyflumetofen, and in particular Appendices I and II thereto, as finalised in the Standing Committee on the Food Chain and Animal Health on 20 November 2012 shall be taken into account.

In this overall assessment, Member States shall pay particular attention to:

—

the protection of operators and workers;

—

the protection of groundwater, in particular for metabolite B3, when the substance is applied in regions with vulnerable soils and/or climatic conditions;

—

the protection of drinking water;

—

the risk to aquatic organisms.

Conditions of use shall include risk mitigation measures, where appropriate.’